JPRN-UMIN000004521
Completed
未知
Early diagnosis of central nervous system involvement of malignant lymphoma by multiplex PCR method - Early diagnosis of central nervous system involvement of malignant lymphoma
ConditionsMalignant Lymphoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Malignant Lymphoma
- Sponsor
- Yokohama City University Hospital
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients without informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Finding early Indicators of Neurological Damage in Sickle Cell Diseasesickle cell diseasestroke100189021000533010007963NL-OMON35805Academisch Medisch Centrum150
Completed
Not Applicable
To establish detecting central nerve resion among vertigo patients in the emergency departmentJPRN-UMIN000004864ational Center for Global Health and Medicine, Japan1,800
Active, not recruiting
Phase 1
P03277 Dose Finding Study in Central Nervous System (CNS)Magnetic Resonance Imaging (MRI)Subject presenting, at the time of inclusion, with known or highly suspected focal areas of disrupted Blood Brain Barrier (BBB)(e.g., primary and secondary tumors, focal inflammatory or demyelinating disorders) including at least one expected enhancinglesion of minimum 5 mm (long axis)MedDRA version: 21.1Level: PTClassification code 10067967Term: Brain injurySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10041552Term: Spinal cord injurySystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 21.1Level: LLTClassification code 10067294Term: Brain lesionSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2014-003576-23-ITGUERBET312
Active, not recruiting
Not Applicable
A Randomized Pilot Study on Central Nervous System (CNS) Prophylaxiswith Liposome-Encapsulated Cytarabine (DepoCyte) in a Population of Adult Patientswith Acute Lymphoblastic Leukemia (ALL) Treated with an Updated and Lineage-TargetedMinimal Residual Disease (MRD)-Oriented Postremission Strategy. - NILG-ALL 10/072. Diagnosis of untreated ALL with B-/T-precursor phenotype or B/T-LL, either de novo or secondary to chemo-radiotherapy for other cancer.MedDRA version: 9.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersEUCTR2007-006652-19-ITILG
Recruiting
Not Applicable
Detection of impaired neural circuits in central nervous system diseases and development of neurophysiological biomarkers for functional brain network abnormalitiescerebrovascular disease, Parkinson's syndrome, essential tremor and epilepsyJPRN-UMIN000022957Osaka university60